CDKN2D and leukemia: To confirm our hypothesis, two human leukemia cell lines, K562 and UT-7 cells and CB-derived CD61+ pro-MKs were transfected with siRNAs against p19INK4D, and examined the effect of RNAi-mediated knockdown of p19INK4D (Figure 7a).